Rheumatism arthritis (RA) is a chronic, systematic, self-immunological disease that primarily affects the joint, resulting in inflammation, pain, swelling and eventual joint damage. Early diagnosis and normative treatment are particularly important because of their high level of disability and their serious impact on the quality of life of patients. 1. Reducing the incidence of disability: Early diagnosis can significantly reduce the incidence of disability caused by rheumatism arthritis. Research shows that early treatment slows the course of disease, protects joint functions and avoids joint malformations and disabilities. Through early intervention, the quality of life of patients can be significantly improved and the incidence of disease-related poverty reduced.
Reduced disease activity: Early diagnosis and treatment can effectively reduce disease activity and inflammation response, thereby reducing joint pain and swelling. Timely treatment can help patients to achieve clinical mitigation or low disease activity in a relatively short period of time, which is important for long-term disease management.
3. Improving long-term prognosis: Early diagnosis and normative treatment can improve not only the short-term symptoms of patients but also the long-term prognosis. Studies have shown that early treatment can slow the progress of the disease and reduce joint damage and functional disorders. Through continuous monitoring and adjustment of treatment programmes, patients can maintain stable conditions over a longer period of time and reduce the risk of relapse.
Improving the efficacy of drugs: Early treatment can improve the efficacy of drugs and reduce their dose and treatment time. The study found that the early use of anti-Rheumatist drugs (DMARDs) to improve the condition could better control disease activity and reduce drug side effects. The use of innovative drugs such as JAK inhibitors in early treatment can further improve treatment effectiveness and reduce the impact of the disease on the lives of patients.
The need for normative treatment
1. Following the principle of conformity treatment: this treatment is an important strategy for the treatment of rheumatism arthritis, requiring patients to start treatment in a timely manner after diagnosis in order to reach the treatment target for clinical mitigation or low disease activity as soon as possible. Ensure that patients reach and maintain a stable state of treatment and reduce the risk of relapse through regular assessment and adjustment of treatment programmes
2. Individualized treatment programme: Rheumatism arthritis is a heterosexual disease, with different patient responses to treatment. It is therefore essential to develop individualized treatment programmes. Doctors should choose appropriate drugs and treatment strategies, depending on the patient ‘ s specific circumstances, including the extent of the disease, the number of accumulated joints, complications, etc.
3. Joint drug strategy: Joint use of multiple drugs can improve treatment effectiveness and reduce the side effects of single drugs. Common joint drug strategies include the joint use of traditional DMARDs with biological agents or target-oriented synthetic DMARDs. Through the joint use of medicines, disease activity can be more comprehensively controlled, joint damage reduced and the quality of life improved.
4. Long-term follow-up and management: Rheumatism arthritis is a chronic disease requiring long-term follow-up and management. Regular medical examinations and assessments help doctors to keep abreast of changes in the patient ‘ s condition and to reorient their treatment. Patients should actively cooperate with the doctor ‘ s treatment programme, take medication on time, review regularly and maintain good living habits to improve the effectiveness of treatment.
5. Psychological support and social care: Rheumatism arthritis not only affects the health of patients but also has a significant impact on their mental health. Psychological support and social care are essential for the rehabilitation of patients. The understanding and support of families and friends can help patients better cope with the challenges posed by disease and improve their quality of life.
Early diagnosis and standardized treatment of rheumatism arthritis are important for reducing disability, reducing disease activity, improving long-term prognosis and improving drug efficacy. The quality of life of patients and the impact of the disease on individuals and society can be significantly improved by following the principles of standard treatment, developing individualized treatment programmes, adopting a joint drug strategy, conducting long-term follow-up and management, and providing psychological support and social care. Increased awareness and attention to rheumatism arthritis and the promotion of early diagnosis and normative treatment are therefore one of the major tasks in the field of medicine.
Rheumatism arthritis
